HDAC1 and central nervous system cancer: In contrast to less efficient discrimination of HDAC2 and HDAC11, the AUC value of HDAC1 over 0.7 throughout the time points manifested that HDAC1 was identified to be a promising prognostic biomarker for glioma (Figures 9A–C; Table 2).